Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · DEFA14A

HeartSciences Inc.

HSCSNASDAQEQUITYCurrent

SEC Filing

Filed Sep 16, 2026Accepted Sep 16, 2026, 5:06 PM EDTCIK 1468492Accession 0001213900-26-100572
Share

Company context

HeartSciences is a healthcare information technology company advancing the use of ECG/EKGs through the integration of artificial intelligence. HeartSciences’ MyoVista Insights™ Platform is a cloud-native, vendor- and device-agnostic ECG management system designed to modernize ECG workflows and improve clinical efficiency and decision-making. The platform’s AI-ECG marketplace is designed to deliver AI-ECG algorithms into clinical workflows across a health system’s existing ECG equipment.

Current securities

Recent company filings

  1. S-3 filingSep 25, 2026
  2. DEFA14A filingSep 24, 2026
  3. DEFA14A filingSep 21, 2026
  4. DEFA14A filingSep 18, 2026
  5. PRER14A filingSep 18, 2026

As-filed source

Primary evidence